20 postdoctoral-fluid-flow PhD positions at University of Nottingham in United Kingdom
Sort by
Refine Your Search
-
demonstrate the utility of an adaptive mesh refinement approach in interface resolving Computational Fluid Dynamics (CFD) simulations of flow boiling at conditions relevant to nuclear thermal hydraulics
-
Institutes (Research Institutes of Sweden) to large industrial manufacturers (UPM-KYMMENE ). The student will also work alongside a Postdoctoral researcher at Nottingham to design and create small scale
-
these robots utilise electronic, chemical, pressure, magnetic, or thermal mechanisms, with the current generation having significant drawbacks, including low energy efficiency, high operating voltage
-
Power Electronics, Machines and Drives Research Group at the University of Nottingham. The PEMC group has undergone a significant period of growth and now has over 150 members, with 18 academics
-
the “Dialling up Performance for on Demand Manufacturing” Programme Grant, which will place the student within an active and supportive team of 9 other PhD students, 15 postdoctoral researchers, 18 world-leading
-
the “Dialling up Performance for on Demand Manufacturing” Programme Grant, which will place the student within an active and supportive team of 9 other PhD students, 15 postdoctoral researchers, 18 world-leading
-
a yearly stipend of £20,780 and is for a period of three years to commence on 1st October 2025. How to apply Applicants should have: A 2.1 or higher honours degree in a social science, and A master's
-
Manufacturing” Programme Grant, which will place the student within an active and supportive team of 9 other PhD students, 15 postdoctoral researchers, 18 world-leading academics from 5 universities, and 11
-
will place the student within an active and supportive team of 9 other PhD students, 15 postdoctoral researchers, 18 world-leading academics from 5 universities, and 11 industry leaders in pharmaceutical
-
stakeholders (including commissioners, patients, clinicians) would like to see in the current treatment gap; followed by an assessment of the new research clinics that explicitly includes these stakeholder